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S U M M A R Y
Streptococcus uberis is an environmental bacterium responsible for bovine mastitis. It is occasionally
described as a human pathogen, though in most cases the identiﬁcation was based on biochemical
phenotyping techniques. This report shows that the biochemical phenotyping may incorrectly identify
Enterococcus faecium as S. uberis.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Streptococcus uberis is an environmental Gram-positive bacte-
rium belonging to the Streptococcaceae family. It is responsible for a
high percentage of mastitis in dairy cattle and it is rarely associated
with human infections.1
In contrast to S. uberis, E. faecium has emerged as an important
nosocomial pathogen, and the treatment of the infections caused
by this bacterium poses a critical challenge due to the ability of
Enterococci to acquire antibiotic resistance.2 Therefore, early
detection of E. faecium is crucial to prevent nosocomial transmis-
sion of this pathogen and to provide the appropriate treatment to
the patients, particularly when it shows a broad range of antibiotic
resistance in patients with impaired host defence, such as those
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).In this report we demonstrate that automated biochemical
phenotyping may erroneously identify E. faecium as S.
uberis. Moreover, a review of the medical literature showed that
the previously reported cases of S. uberis infections were based on
biochemical identiﬁcation, thus raising serious concern about the
real occurrence of S. uberis in humans. Our data strongly suggest that
the presence of this bacterium must always be supported by more
speciﬁc identiﬁcation procedures such as genotypic methods.1,3
2. Case Report
In January 2014 a 67-year-old man, presenting with abdominal
pain, fever, leucocytosis and abdominal soft tissue infection was
admitted to our Institution. The past medical history included
hypertension and left colic resection with splenectomy for bowel
obstruction due to colonic cancer with synchronous hepatic
metastasis (T3N0M1).
On admission, computed tomography scan revealed necrosis of
the right lobe lesion in the liver and gallbladder perforation causedciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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performed and the microbiological assessment indicated the
presence of gram-positive, b-Glucuronidase positive cocci, identi-
ﬁed as Streptococcus uberis with a 95% probability by the VITEK
2 system (BioMe´rieux Inc.). According to the microbiological
results and the antibiotic susceptibility proﬁles (Table 1), the ﬁrst
empirical antibiotic treatment with tazobactam/piperacillina and
metronidazole was substituted with vancomycin and the patient
was subjected to parenteral nutrition. Since S. uberis is a pathogen
mainly associated with mastitis in dairy cows, this unusual
bacterial identiﬁcation compelled the microbiologists to repeat the
test for conﬁrmation. The second round of analysis by the VITEK
2 system conﬁrmed the previous identiﬁcation of S. uberis.
However, a few days later, microbiological testing by VITEK 2 of
newly collected samples yielded gram-positive, b-Glucuronidase
negative cocci, identiﬁed as Enterococcus faecium with a 95%
certainty. Surprisingly, further testing, performed three days later,
showed again the presence of S. uberis with a 95% identiﬁcation
conﬁdence.
No additional microorganisms were isolated. Thus, to obtain a
clear bacterial identiﬁcation, the samples were ﬁrst analysed by
matrix assisted laser desorption/ionisation – time of ﬂight mass
spectrometry (MALDI-TOF MS system – Bruker Daltonics, Bremen,
Germany), which classiﬁed the bacterium as E. faecium and
subsequently, sequence analysis (ABI PRISM 3130xl Genetic
Analyzer) of the 16S rRNA gene conﬁrmed that the bacterium
was E. faecium (99,4% sequence similarity and 100% sequence
coverage).
As the clinical conditions did not improve, the patient
underwent a resection of hepatic residual metastases with
cholecystectomy and abdominal surgical toilette. The postopera-
tive course was complicated by a low-grade hepatic failure that
required intensive care for ﬁve days.
The patient was then discharged in good clinical condition with
abdominal drainage for a moderate biliary leakage and conserva-
tive treatment.
3. Discussion
Infections caused by Enterococci are continuously increasing,
representing one of the leading causes of nosocomial infections,
mostly affecting the the bloodstream, urinary tract, perineal skin
and surgical wounds. An important cause for the increased
frequency of E. faecium as a nosocomial pathogen is the capacity
to acquire novel adaptive traits, including genetic elements
encoding antibiotic resistance determinants.2
In routine clinical microbiology, the detection of Enterococci is
generally performed by biochemical characterization. However,Table 1
Antibiotic susceptibility pattern of the isolated bacteria
Antibiotic tested MIC Test Result
Ampicillin I 16 mcg/ml R
Cefotaxime I 8 mcg/ml R
Ceftriaxone I 8 mcg/ml R
Clindamycin I 1 mcg/ml R
Erythromycin I 8 mcg/ml R
Levoﬂoxacin I 16 mcg/ml R
Linezolid 2 mcg/ml S
Penicillin G 8 mcg/ml R
Tetracycline I 16 mcg/ml R
Vancomycin 1 mcg/ml S
Ampicillin/Sulbactam I 32 mcg/ml R
Chinupristin/Dalfopristin 0.5 mcg/ml R
Teicoplanin = 0.5 mcg/ml S
Tigecycline = 0.12 mcg/ml S
MIC: Minimal Inhibitory Concentration according to EUCAST 4.0 methodology; R:
resistant; S: Sensitive.this procedure has often failed the identiﬁcation and antimicrobial
susceptibility proﬁling of enterococci.4,5 A commercial biochemi-
cal kit used for the detection of non-human enterococcal isolates
showed inconsistencies in genus and species identiﬁcation.6 A
study conducted by Ligozzi et al. documented the inability of VITEK
2 to correctly identify E. faecium (71,4% correct).7 Garcia-Garrote
et al. reported a rate of accuracy in E. faecium identiﬁcation of 76.3%
using the VITEK 2 system.8 In particular, half of the misidentiﬁca-
tions were due to E. faecium with low-level resistance to
vancomycin (LRV).8 This is in accordance with the data reported
in Abele-Horn et al. where the VITEK 2 system correctly identiﬁed
all vancomycin resistant E. faecium strains while all isolates
identiﬁed with low discrimination were E. faecium LRV.9 The E.
faecium described in the present report corresponds to an LRV
strain (Table 1) and this may, at least in part, explain the incorrect
identiﬁcation by the VITEK 2. However, this does not explain why it
was classiﬁed as S. uberis.
S. uberis is an opportunistic pathogen in dairy cattle, adapted to
challenging and changing environmental conditions and capable of
a nutritional ﬂexibility based on multiple metabolic options.10 In-
vitro experiments demonstrated that S. uberis can readily develop
penicillin resistance, and microbial analysis of bacterial population
in treated milk showed that S. uberis can grow even in cold
storage.11,12 It has been hypothesized that the stability of this
pathogen under various environmental conditions and the
expression of virulence factors11–13 may expand the pathogenicity
of this bacterium from cattle to humans as described for
Streptococcus agalactiae, a pathogen that is associated with both
animal and human diseases.14 However, few data provide support
for this hypothesis, and in many cases the tests used for the
identiﬁcation of S. uberis in humans have been debated.1,3
Additionally, S. uberis in combination with other bacteria was
used as a probiotic in a clinical trial aimed at contrasting the
growth of periodontal pathogens. The results as well as a toxicity
study conducted in rats revealed no adverse-effect of the probiotic
mouthwash by daily usage, which on the other hand contributed to
maintaining both dental and periodontal health.15,16
Nevertheless, in 1988 Rabe reported a case of genital infection
in a human due to S. uberis and in 1989 Sarkar described a
pneumonia infection caused by an S. uberis sensitive to penicillin.1
In 1991 Sanchez reported a single case of hepatic abscess of a cattle
man and in 1999 Bouskraoui isolated an S. uberis strain sensitive to
penicillin-G and amoxicillin from an 11 month old infant. Haffajee
in 1988 and Dzink in 1989 identiﬁed S. uberis from periodontal
tissues, suggesting that it may represent an oral commensal
rather than an oral pathogen in humans.1 Lazin´ska described a
microbiological urinalysis of 269 patients after renal transplanta-
tion, and identiﬁed one patient with an infection of S. uberis.17
Velez-Montoya reported a postoperative endophthalmitis caused
by S. uberis that was resistant to the majority of the latest
generation of antibiotics however, the method used for the
identiﬁcation was not mentioned and the reliability of the
recognition was questioned.1,3 Recently, Gu¨len and collaborators
identiﬁed S. uberis from urine samples of seven of 148 patients by
phenotypic methods.18
The common feature of all cases of human infection supposedly
caused by S. uberis is that the detection was obtained by phenotypic
bacterial identiﬁcation systems. Therefore, it is possible that the real
occurrence of this infection has been overrepresented and that the
previously reported incidence of S. uberis in association with various
human infections may depend on the inappropriate identiﬁcation by
conventional phenotypic methods.
In our report, the identiﬁcation of the isolate as S. uberis relies
on the presence of b-Glucuronidase positive tests, and the negative
growth in 6.5% of NaCl. The growth in 6.5% NaCl may not represent
a valuable discriminatory test for enterococci and streptococci. On
E.G. Di Domenico et al. / International Journal of Infectious Diseases 33 (2015) 79–81 81the contrary, b-Glucuronidase activity is an important biochemical
parameter for the identiﬁcation of S. uberis as E. faecium is normally
b-Glucuronidase negative.2 Nevertheless, a comparative analysis
of the genome of an emerging epidemic hospital strain of E. faecium
(Aus0085) isolated in Australia and now widespread from Europe
to Asia, predicted the presence of the b-Glucuronidase gene.2 From
this study it appears that many of the nosocomial E. faecium strains
contain a high number of mobile genetic elements that distinguish
them from community-acquired and non-pathogenic strains. It has
been estimated that 24% of the E. faecium Aus0085 genes are
located on the six plasmids, demonstrating that this element has a
critical role in the transmission of speciﬁc traits to other clinical E.
faecium isolates.2 b-Glucuronidase gene catalyses the breakdown
of complex carbohydrates, and this gene might confer a survival
and growth advantage in hospital environments.
Similar concerns regarding the low discrimination of pheno-
typic tests have emerged previously for coagulase-negative
staphylococci, suggesting that ambiguous test results might lead
to misidentiﬁcation of bovine pathogens as human pathogens.19
In addition to the biochemical phenotyping, different molecular
methods have been developed to characterise S. uberis and
sequence-based identiﬁcation emerging as a powerful diagnostic
technique that can be applied to routine clinical isolates. Indeed,
the Clinical and Laboratory Standards Institute (CLSI) published a
document to speciﬁcally address the criteria used for identiﬁcation
of bacteria and fungi establishing that genotypic methods have to
be preferred over phenotypic systems, encouraging the imple-
mentation of such techniques by diagnostic laboratories.20
In summary, this report describes a case of erroneous identiﬁca-
tion of E. faecium with S. uberis by biochemical phenotyping. This
ﬁnding reinforces the doubts previously reported in the literature
concerning the possible pathogenicity of S. uberis in humans and
points to the limitation of phenotypic tests, suggesting that the
identiﬁcation of this pathogen must always be supported by more
speciﬁc procedures such as genotypic methods. This is particularly
important in immunocompromised patients, such as those affected
by cancer and undergoing intensive chemotherapy where the
appropriate antibiotic therapy should be started as soon as the
pathogen is detected.
Funding: EGDD has a fellowship from l’Associazione Nazionale
Contro le Infezioni Ospedaliere (L’ANCIO).
Conﬂict of interest: The authors declare that they have no
competing interests or funding.
References
1. Zadoks RN. Sources and epidemiology of Streptococcus uberis, with special
emphasis on mastitis in dairy cattle. CAB Reviews 2007;2:30.2. Lam MMC, Seemann T, Tobias NJ, Chen H, Haring V, Moore RJ, et al. Comparative
analysis of the complete genome of an epidemic hospital sequence type
203 clone of vancomycin-resistant Enterococcus faecium. BMC Genomics
2013;14:595.
3. Toma L, Di Domenico EG, Prignano G, Ensoli F. Comment on Intravitreal
Ampicillin Sodium for Antibiotic-Resistant Endophthalmitis: Streptococcus
uberis First Human Intraocular Infection Report. J Ophthalmol 2014;2014:
395480.
4. Okabe T, Oana K, Kawakami Y, Yamaguchi M, Takahashi Y, Okimura Y, et al.
Limitations of vitek GPS-418 cards in exact detection of vancomycin-resistant
enterococci with the vanB genotype. J Clin Microbiol 2000;38:2409–11.
5. Eisner A, Gorkiewicz G, Feierl G, Leitner E, Ko¨fer J, Kessler HH, et al. Identiﬁca-
tion of glycopeptide-resistant enterococci by VITEK 2 system and conventional
and real-time polymerase chain reaction. Diagn Microbiol Infect Dis 2005;53:
17–21.
6. Hudson CR, Fedorka-Cray PJ, Jackson-Hall MC, Hiott LM. Anomalies in species
identiﬁcation of enterococci from veterinary sources using a commercial bio-
chemical identiﬁcation system. Lett Appl Microbiol 2003;36:245–50.
7. Ligozzi M, Bernini C, Bonora MG, De Fatima M, Zuliani J, Fontana R. Evaluation of
the VITEK 2 system for identiﬁcation and antimicrobial susceptibility testing of
medically relevant gram-positive cocci. J Clin Microbiol 2002;40:1681–6.
8. Garcia-Garrote F, Cercenado E, Bouza E. Evaluation of a new system, VITEK 2, for
identiﬁcation and antimicrobial susceptibility testing of enterococci. J Clin
Microbiol 2000;38:2108–11.
9. Abele-Horn M, Hommers L, Trabold R, Frosch M. Validation of VITEK 2 version
4.01 software for detection, identiﬁcation, and classiﬁcation of glycopeptide-
resistant enterococci. J Clin Microbiol 2006;44:71–6.
10. Ward PN, Holden MT, Leigh JA, Lennard N, Bignell A, Barron A, et al. Evidence for
niche adaptation in the genome of the bovine pathogen Streptococcus uberis.
BMC Genomics 2009;10:54–71.
11. Haenni M, Galofaro L, Ythier M, Giddey M, Majcherczyk P, Moreillon P, et al.
Penicillin-binding protein gene alterations in Streptococcus uberis isolates pre-
senting decreased susceptibility to penicillin. Antimicrob Agents Chemother
2010;54:1140–5.
12. Rasolofo EA, St-Gelais D, LaPointe G, Roy D. Molecular analysis of bacterial
population structure and dynamics during cold storage of untreated and
treated milk. Int J Food Microbiol 2010;138:108–18.
13. Haenni M, Saras E, Madec JY. Demonstration of a shift towards penicillin
resistance in the Streptococcus uberis population. J Med Microbiol 2010;59:
993–5.
14. Zadoks RN, Middleton JR, McDougall S, Katholm J, Schukken YH. Molecular
epidemiology of mastitis pathogens of dairy cattle and comparative relevance
to humans. J Mammary Gland Biol Neoplasia 2011;16:357–72.
15. Zahradnik RT, Magnusson I, Walker C, McDonell E, Hillman CH, Hillman JD.
Preliminary assessment of safety and effectiveness in humans of ProBiora3, a
probiotic mouthwash. J Appl Microbiol 2009;107:682–90.
16. Hillman JD, McDonell E, Hillman CH, Zahradnik RT, Soni MG. Safety assessment
of ProBiora3, a probiotic mouthwash: subchronic toxicity study in rats. Int J
Toxicol 2009;28:357–67.
17. Lazinska B, Ciszek M, Rokosz A, Sawicka-Grzelak A, Paczek L, Luczak M.
Bacteriological urinalysis in patients after renal transplantation. Pol J Microbiol
2005;54:317–21.
18. Gu¨len D, Kaya AD, Aydin M, Tanriverdi Y. Urinary tract infections caused by
Streptococcus uberis: A pathogen of bovine mastitis report of seven cases. African
Journal of Microbiology Research 2013;7:3908–12.
19. Sampimon OC, Zadoks RN, De Vliegher S, Supre´ K, Haesebrouck F, Barkema HW,
et al. Performance of API Staph ID 32 and Staph-Zym for identiﬁcation of
coagulase-negative staphylococci isolated from bovine milk samples. Vet
Microbiol 2009;136:300–5.
20. CLSI (Clinical Laboratory Standards Institute), 2007. Interpretive criteria for
microorganism identiﬁcation by DNA target sequencing; proposed guideline.
In: CLSI document MM18-P (ISBN 1-56238-646-8), Clinical and Laboratory
Standards Institute, Wayne, PA.
